Together with evidence that Ang II induces MMP-9 via NF-κB in vascular smooth muscle and immune cells, these findings support renin–angiotensin blockade as a strategy to recalibrate MMP-9 homeostasis in vascular walls, myocardium, and aneurysm models. This evidence concerns the gene NFKB1 and aneurysm.